Introducing way more signals! We've added more signal sources to capture the full customer journey.

Learn More!
PIVOTAL BIOVENTURE PARTNERS

PIVOTAL BIOVENTURE PARTNERS

Pivotal bioVenture Partners, founded in 2017, is a $300 million life sciences venture capital fund, funded by the Nan Fung Group. We invest in privately-held North American and European companies focused on innovative therapeutic products and platforms to address major unmet medical needs. We invest at all stages in a company's evolution, from company creation through to mezzanine financings. We support development programs from preclinical through all the stages of clinical development and onto the market. We typically lead or co-lead our investments and aim to invest $20-25 million into each portfolio company. Our team brings diverse experience in venture capital, company building, and drug discovery and development, partnering with entrepreneurs to advance their businesses.

Last updated on

About PIVOTAL BIOVENTURE PARTNERS

Estimated Revenue

$1M-$10M

Employees

11-50

Category

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Location

City

San Francisco

State

California

Country

United States
PIVOTAL BIOVENTURE PARTNERS

PIVOTAL BIOVENTURE PARTNERS

Find your buyer within PIVOTAL BIOVENTURE PARTNERS

Tech Stack (28)

search